L'Occitane sells Elemis to PAI Partners after seven years of ownership

Elemis has changed hands for an undisclosed sum, with L'Occitane Group selling the British skin care brand to private equity firm PAI Partners after seven years of ownership. The deal closes a chapter that saw Elemis nearly double net sales to more than US$300m in FY2026, according to figures cited by the seller.

For formulators, buyers and spa operators who stock the brand, the more consequential numbers sit underneath the headline. The US now accounts for approximately 50% of Elemis net sales, following several years of double-digit annual growth and sustained investment in the American market since 2015. An estimated half of total sales already run through digital channels, split between the brand's own direct-to-consumer platform and leading digital retail partners.

What does the new owner intend to change?

PAI Partners said it will work closely with the existing Elemis management team, and its stated priorities are concrete enough to map against product and channel plans. The firm wants to reinforce the brand's leadership in the UK while accelerating expansion in the US, broaden distribution through digital and selected premium retail channels, and keep investing in the core product range.

Product innovation will build on the Pro-Collagen franchise, the hero range that anchors the portfolio. For procurement teams and retail buyers, that signals continuity rather than a reformulation reset — at least for now.

"Elemis is a distinctive British skin care brand with exceptional products, a strong commitment to innovation and a loyal global following," said Gaëlle d'Engremont and Colm O'Sullivan, Partners at PAI Partners. "Its premium positioning, clinically proven product performance, and strong digital engagement set it apart in an attractive and resilient skin care market."

The pair added: "We see significant opportunities to accelerate growth in the US and expand the brand's digital business, while preserving its distinctive British identity."

Read that as a private equity thesis: scale what already works — US distribution and the D2C engine — rather than reposition the brand. The mention of "clinically proven product performance" also suggests claims substantiation will remain central to how Elemis markets itself, which matters for compliance teams tracking the brand's evidence base.

Why is L'Occitane Group selling?

Elemis was L'Occitane Group's first major acquisition, and Reinold Geiger, Chairman and CEO, framed the sale as portfolio housekeeping rather than a verdict on the asset.

"Elemis has played a special role in the history of our group," Geiger said. "As our first major acquisition, it marked an important step in our evolution as a true multi-brand group."

He continued: "This transaction reflects a disciplined portfolio decision, focused on creating long-term value for the group."

The group credited the seven-year tenure with strengthened brand equity and expanded global commercial partnerships alongside the near-doubling of net sales. Geiger thanked the brand for its contribution and said he was proud of the growth created together.

Who stays at the helm?

Noella Gabriel, who co-founded Elemis in London in 1989 alongside entrepreneur and investor Linda Steiner, Sean Harrington and Oriele Frank, remains CEO. Management continuity under a financial owner typically shortens the integration period, and Gabriel's statement pointed to extension rather than reinvention.

"Over the past seven years, with the support of L'Occitane Group, we have strengthened and grown the Elemis business, built a compelling product proposition, and created a truly differentiated customer and retail experience," Gabriel said.

She added: "We are grateful to L'Occitane Group for its support and excited to take Elemis into its next phase of growth in partnership with PAI Partners."

What happens next?

Watch three things. First, whether PAI Partners discloses the transaction price in regulatory filings, which would set a valuation benchmark for premium skin care assets. Second, the pace of US retail expansion under the new owner, given the market already delivers roughly half of sales. Third, the next wave of Pro-Collagen launches, the clearest signal of whether the innovation pipeline survives the ownership change intact.

By Rebecca Stone